2 Insurance Stocks to Buy That Keep About 16 Cents of Every Premium Dollar as Underwriting Profit

Travelers reported a third-quarter 2026 underlying combined ratio of 84.1%, while Chubb recorded ratios of 81.3% in U.S. operations, 86.4% internationally and 80.7% in reinsurance, indicating profitable underwriting. Travelers and Chubb hold investment portfolios of $100 billion and $172 billion, respectively, and earned nearly $1.1 billion and more than $1.7 billion in investment income in Q2 2026. Rising interest rates can pressure bond prices, though insurers often hold bonds to maturity; both stocks trade above their five-year-average price-to-book ratios and offer dividend yields just over 1%.

Analysis

The investable mechanism is the interaction between underwriting discipline and reinvestment yields—not simply the current investment-income run rate. Higher market yields can pressure bond marks and reported book value near term, while gradually lifting portfolio income as maturities and premiums are reinvested. That benefit is conditional: duration, liability matching, and capital treatment matter, so verify portfolio duration and unrealized-loss/AOCI sensitivity before treating the rate move as a tailwind.

The main downside is correlated: catastrophe losses, claims-cost inflation, or softer renewal pricing can erode underwriting margins just as elevated price-to-book multiples leave less room for disappointment. “Underlying” combined ratios also need to be checked against reported ratios, catastrophe impacts, and prior-year reserve development. Chubb’s broader mix may diversify exposures, but the quoted U.S., foreign, and reinsurance ratios are not directly comparable with Travelers’ underlying figure; they do not establish a relative-value case.

Timing: over days, rate volatility can dominate insurer book-value sentiment. Over 1–3 months, earnings detail and renewal pricing should test whether underwriting remains durable and whether reinvestment income is accelerating. Over 6–18 months, persistent underwriting profits plus higher reinvestment yields could compound float income; a turn in pricing or elevated catastrophe losses would break that thesis. The contrarian point is that investors may overfocus on bond marks, but the offset is that the market may already price in much of the quality: both stocks’ above-average price-to-book multiples weaken the case for chasing. No clean pair trade is supported by the supplied, non-comparable ratio data.

Key Decisions for Investors

• Avoid chasing either stock solely on the reported underwriting ratios. Consider staged exposure to TRV or CB only on a broader pullback, with position sizing contingent on reported—not only underlying—combined ratios, catastrophe losses, and reserve development.
• At the next earnings and renewal updates, track pricing versus claims-cost inflation and the gap between underlying and reported combined ratios. A sustained deterioration in that gap or evidence of reserve strengthening would falsify the underwriting-quality thesis and argue for reducing exposure.
• Monitor portfolio duration, unrealized bond losses/AOCI, and reinvestment yields. Treat rising yields as a near-term mark-to-market risk and a conditional medium-term income tailwind, not an automatic earnings positive.
• No CB-versus-TRV pair recommendation: the cited business scopes differ, and the supplied facts do not establish relative valuation, catastrophe-adjusted profitability, or balance-sheet sensitivity. Reassess after comparable segment and capital disclosures.